Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Shanghai International Convention Center

May 24, 2015 8:30 AM - May 27, 2015 5:00 PM

No. 2727, Riverside Avenue, Pudong, 200120 Shanghai, China

The 7th DIA China Annual Meeting

Back to Agendas

Session 0302 The Feasibility of Initiating Clinical Trials by Single IRB Approving in China

Session Chair(s)

Shuting Li, MD

Deputy Director

GCP Alliance, China, China

Opening

Speaker(s)

George Guo

Novartis Pharmaceuticals, China

Global Monitoring Operation Country Head

Winnie Xu

Quintiles Medical Development (Shanghai) Co. Ltd, China

Huanling Wang

Peking Union Medical College Hospital, China

Vice Director, Clinical Pharmacology Research Center

What will be reviewed in multicenter ethical review units should review what?

YongChuan Chen

Xinan Hospital of Army Medical University, China

Director,Drug Clinical Trial Institute Office

Zhiqiang Ning

Shenzhen Chipscreen Biosciences, Ltd., China

Vice President, Research & Clinical Development

The feasibility of center ethical review implementation in China

Tim Shi

GlobalMD, United States

Executive Director

Have an account?